On Sept. 27, in a university-wide email, CEO of Yale Health Paul Genecin announced that Yale community members aged 65 and older or at increased […]
September 27, 2021
As the Yale New Haven Health System continues to monitor breakthrough infections, noting low infection rates among the vaccinated, it has also seen a significant decrease in COVID-19 patients.
September 24, 2021
The effectiveness of masks in preventing COVID-19 has been supported by the results of a 300,000-person randomized trial in Bangladesh led by two School of Management researchers.
September 13, 2021
Scientists at the Yale School of Medicine conducted a study to investigate the effect of T-cells and B-cells in adaptive immunity and what that could mean for future treatments against COVID-19.
September 12, 2021
In a Thursday press conference, Yale New Haven Health system officials explained that approximately six percent of patients who test positive for COVID-19 and are symptomatic are fully vaccinated.
A Yale School of Public Health study conducted in collaboration with the state found that some nursing home residents experienced repeat positive COVID-19 tests.
September 9, 2021
Scientists at the medical school used microscopic technology to image COVID-19 infection in mice, which will hopefully aid in developing treatments.
September 8, 2021
Researchers used modeling techniques to estimate the number of lives saved and hospitalizations prevented due to the U.S. vaccine rollout compared to the result if no vaccines had been administered.
September 2, 2021
Public health researchers shared their thoughts on the equity of global vaccine distribution at a June event hosted by the School of Medicine.
Yale researchers found that including dollar stores in the U.S. vaccine distribution process would aid in the country’s efforts to reach marginalized populations.
May 7, 2021
Multisystem inflammatory syndrome is a serious, yet puzzling, disease that can present in children weeks after they have been infected with COVID-19. To better understand the mechanisms that underlie it, scientists in the Lucas Lab have immunologically profiled the condition.